MITOMYCIN is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Mitomycin.
Product ID | 71288-138_a78f4900-61e4-4e22-bfcb-6b5210c94c57 |
NDC | 71288-138 |
Product Type | Human Prescription Drug |
Proprietary Name | MITOMYCIN |
Generic Name | Mitomycin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-09-08 |
Marketing Category | ANDA / |
Application Number | ANDA214505 |
Labeler Name | Meitheal Pharmaceuticals Inc. |
Substance Name | MITOMYCIN |
Active Ingredient Strength | 20 mg/40mL |
Pharm Classes | Alkylating Activity [MoA], Alkylating Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-09-08 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9135 | Mitomycin | Mitomycin |
0143-9136 | Mitomycin | Mitomycin |
0143-9279 | Mitomycin | Mitomycin |
0143-9280 | Mitomycin | Mitomycin |
16729-108 | Mitomycin | Mitomycin |
16729-115 | Mitomycin | Mitomycin |
16729-116 | Mitomycin | Mitomycin |
16729-246 | Mitomycin | Mitomycin |
16729-247 | Mitomycin | Mitomycin |
16729-248 | Mitomycin | Mitomycin |
67457-518 | Mitomycin | Mitomycin |
67457-519 | Mitomycin | Mitomycin |
67457-520 | Mitomycin | Mitomycin |
67457-995 | Mitomycin | Mitomycin |
67457-996 | Mitomycin | Mitomycin |
67457-997 | Mitomycin | Mitomycin |
68001-389 | Mitomycin | Mitomycin |
68001-390 | Mitomycin | Mitomycin |
68001-391 | Mitomycin | Mitomycin |
68083-483 | MITOMYCIN | MITOMYCIN |
68083-484 | MITOMYCIN | MITOMYCIN |
68083-502 | MITOMYCIN | MITOMYCIN |
71288-137 | MITOMYCIN | MITOMYCIN |
71288-138 | MITOMYCIN | MITOMYCIN |
69605-103 | JELMYTO | mitomycin |
49771-002 | Mitosol | mitomycin |
69448-001 | MUTAMYCIN | Mitomycin |
69448-002 | MUTAMYCIN | Mitomycin |
69448-003 | MUTAMYCIN | Mitomycin |